Updated:
MatsukiyoCocokara & Co./ADR
MatsukiyoCocokara & Co./ADR is an investment vehicle tied to Japan's largest drugstore chain. Structure and wealth origins are disclosed.
MatsukiyoCocokara & Co./ADR
MatsukiyoCocokara & Co./ADR serves as an investment entity affiliated with MatsukiyoCocokara & Co., Japan's leading drugstore chain formed in 2021 through the merger of Matsumotokiyoshi and Cocokara Fine. The firm manages capital from the founding families and corporate treasury, with a mandate that includes public equities, real estate, and private investments. The strategy emphasizes Japanese equities and ADR structures, with known exposure to healthcare and retail sectors. Real estate holdings include properties supporting the parent's store network. The firm does not publicly disclose a direct investment portfolio, but its parent's financial filings indicate stakes in over 200 retail locations nationwide. Scale is not publicly disclosed, with no AUM or professional count available. The entity is based in Japan and maintains no additional offices. No recent operational events have been reported. The firm's structure as a family office linked to a publicly traded parent is rare, allowing it to leverage corporate balance sheet strength while maintaining privacy. Its ADR vehicle provides U.S. investors access to Japanese retail capital, but governance details remain opaque.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
Who runs investment decisions at MatsukiyoCocokara & Co./ADR?
No named investment professionals are publicly disclosed. The firm is an affiliate of MatsukiyoCocokara & Co., whose board oversees corporate investments. The founding families of the predecessor chains may influence decisions, but specific individuals are unidentified.
How does MatsukiyoCocokara & Co./ADR source proprietary deal flow?
Proprietary sourcing is likely through the parent's retail operations and real estate footprint. The firm may have access to healthcare and pharmacy-related private deals in Japan, though no explicit sourcing method is disclosed.
Is MatsukiyoCocokara & Co./ADR structured as a single family office or does it operate more like a venture firm?
The entity functions as a family office tied to the MatsukiyoCocokara corporate structure, not a venture firm. Its ADR issuance suggests a vehicle for capital management rather than active venture investing.
Does MatsukiyoCocokara & Co./ADR participate in fund commitments or only direct deals?
Public filings show indirect exposure through its parent's investments, but no direct fund commitments are reported. The firm likely engages in direct real estate holdings and equity stakes via ADRs.
What investment stages does MatsukiyoCocokara & Co./ADR typically target?
Target stages are unclear due to limited transparency, but the portfolio is weighted toward established public equities and tangible real estate, indicating a growth or income-focused mandate rather than early-stage venture.
Which sectors does MatsukiyoCocokara & Co./ADR explicitly avoid?
No explicit avoidance sectors are documented. Given the parent's pharmacy and cosmetics focus, technology or high-risk sectors may be underrepresented, but no formal exclusions exist.
How is MatsukiyoCocokara & Co./ADR related to its parent company?
MatsukiyoCocokara & Co./ADR is a class of depositary receipt issued by MatsukiyoCocokara & Co., the parent publicly traded on the Tokyo Stock Exchange. The ADR vehicle allows U.S. investors to hold shares, while the family office arm manages wealth from the parent's founding families and retained earnings.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: